Combined iStent trabecular micro-bypass stent implantation and phacoemulsification for coexistent open-angle glaucoma and cataract: A long-term study

British Journal of Ophthalmology

Volumn 96, Issue 5, 2012, Pages 645-649

  Arriola Villalobos, Pedro ^a   Martínez de la Casa, José Maria ^b   Díaz Valle, David ^b   Fernández Pérez, Cristina ^a   García ánchez, Julián ^b,c   García Feijoó, Julián ^b,c  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGLAUCOMA AGENT;

ADULT; AGED; ARTICLE; CASE STUDY; CATARACT; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE SEVERITY; FEMALE; FOLLOW UP; GONIOSCOPY; HUMAN; IMPLANTATION; INTERVENTION STUDY; INTRAOCULAR PRESSURE; LENS IMPLANTATION; MALE; OPEN ANGLE GLAUCOMA; PHACOEMULSIFICATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOEXFOLIATION; STENT IMPLANTATION; VISUAL ACUITY;

AGED; ANTIHYPERTENSIVE AGENTS; CATARACT; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA DRAINAGE IMPLANTS; GLAUCOMA, OPEN-ANGLE; GONIOSCOPY; HUMANS; INTRAOCULAR PRESSURE; MALE; PHACOEMULSIFICATION; PROSPECTIVE STUDIES; PROSTHESIS IMPLANTATION; STENTS; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL FIELD TESTS;

EID: 84860218945     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2011-300218     Document Type: Article

References (19)

1. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006;90:262-7. (Pubitemid 43325451)
2. Leske MC, Heijl A, Hyman L, et al. Factors for progression and glaucoma treatment: the early Manifest glaucoma trial. Curr Opin Ophthalmol 2004;15:102-6. (Pubitemid 38457128)
3. Jampel HD, Musch DC, Gillespie BW, et al. Perioperative complications of trabeculectomy in the collaborative initial glaucoma treatment study (CIGTS). Am J Ophthalmol 2005;140:16-22. (Pubitemid 41008085)
4. Ang GS, Varga Z, Shaarawy T. Postoperative infection in penetrating versus nonpenetrating glaucoma surgery. Br J Ophthalmol 2010;94:1571-6.
5. DeBry PW, Perkins TW, Heatley G, et al. Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin. Arch Ophthalmol 2002;120:297-300. (Pubitemid 34250049)
6. Poley BJ, Lindstrom RL, Samuelson TW, et al. Intraocular pressure reduction after phacoemulsification with intraocular lens implantation in glaucomatous and nonglaucomatous eyes: evaluation of a causal relationship between the natural lens and open-angle glaucoma. J Cataract Refract Surg 2009;35:1946-55.
7. Shrivastava A, Singh K. The effect of cataract extraction on intraocular pressure. Curr Opin Ophthalmol 2010;21:118-22.
8. Spiegel D, Kobuch K. Trabecular meshwork bypass tube shunt: initial case series. Br J Ophthalmol 2002;86:1228-31. (Pubitemid 35238599)
9. Bahler CK, Smedley GT, Zhou J, et al. Trabecular bypass stents decrease intraocular pressure in cultured human anterior segments. Am J Ophthalmol 2004;138:988-94. (Pubitemid 40040014)
10. Fernández-Barrientos Y, García-Feijoó J, Martínez-de-la-Casa JM, et al. Fluorophotometric study of the effect of the glaukos trabecular microbypass stent on aqueous humor dynamics. Invest Ophthalmol Vis Sci 2010;51:3327-32.
11. Spiegel D, Wetzel W, Haffner DS, et al. Initial clinical experience with the trabecular micro-bypass stent in patients with glaucoma. Adv Ther 2007;24:161-70. (Pubitemid 46700875)
12. Spiegel D, García-Feijoó J, García-Sánchez J, et al. Coexistent primary open-angle glaucoma and cataract: preliminary analysis of treatment by cataract surgery and the iStent trabecular micro-bypass stent. Adv Ther 2008;25:453-64.
13. Spiegel D, Wetzel W, Neuhann T, et al. Coexistent primary open-angle glaucoma and cataract: interim analysis of a trabecular micro-bypass stent and concurrent cataract surgery. Eur J Ophthalmol 2009;19:393-9.
14. Fea AM. Phacoemulsification versus phacoemulsification with micro- bypass stent implantation in primary open-angle glaucoma: randomized double-masked clinical trial. J Cataract Refract Surg 2010;36:407-12.
15. Samuelson TW, Katz LJ, Wells JM, et al. Randomized evaluation of the trabecular micro-bypass stent with phacoemulsification in patients with glaucoma and cataract. Ophthalmology 2011;118:459-67.
16. Hodapp E, Parrish RK, Anderson DR. Initial treatment of primary open-angle glaucoma. In: Hodapp E, Parrish RK, Anderson DR. Clinical Decisions in Glaucoma. St. Louis: Mosby, 1993:52-9.
17. Singh K, Lee BL, Wilson MR; Glaucoma Modified RANDLike Methodology Group. A panel assessment of glaucoma management: modification of existing RAND-like methodology for consensus in ophthalmology. Part II: results and interpretation. Am J Ophthalmol 2008;145:575-81.
18. Baudouin C, Pisella PJ, Fillacier K, et al. Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies. Ophthalmology 1999;106:556-63. (Pubitemid 30191592)
19. Broadway DC, Grierson I, O'Brien C, et al. Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery. Arch Ophthalmol 1994;112:1446-54. (Pubitemid 24350507)